Benzinga | Jan 12, 2021 06:13AM EST

Immatics Biotechnologies Awarded U.S. Patent 10,888,587 "Peptides and combination of peptides for use in immunotherapy against epithelial ovarian cancer and other cancers"

Immatics Biotechnologies Awarded U.S. Patent 10,888,587 "Peptides and combination of peptides for use in immunotherapy against epithelial ovarian cancer and other cancers"